Kyri van Hoose
Financieel Directeur/CFO bij DERMATA THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Kyri van Hoose
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TURG POIN | Comptroller/Controller/Auditor | 05-05-2021 | - |
| DERMATA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-09-2021 | - |
Loopbaan van Kyri van Hoose
Eerdere bekende functies van Kyri van Hoose
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TEGA Therapeutics, Inc.
 TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Financieel Directeur/CFO | 01-09-2020 | 30-04-2021 |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-11-2019 | 01-04-2020 |
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01-09-2005 | 01-02-2016 |
Opleiding van Kyri van Hoose
| University of Southern California | Undergraduate Degree |
| University of California, Irvine | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Health Technology |
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Kyri van Hoose
- Ervaring